Differential effects of glucose

The incretin hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are important regulators of many aspects of metabolism including insulin secretion. Their receptors (GIPR and GLP-1R) are closely related members of the secretin class of G-protein-coupled r …

Impact of glucose-dependent insulinotropic polypeptide receptor and glucagon-like petide-1 receptor heteromerization on cell signalling.
Key Details About Differential Effects Of Glucose Dependent Insulinotropic

Glucose-dependent insulinotropic peptide (GIP) has been reported to have opposing effects on splanchnic blood flow. GIP infusion in dogs results in an increase in portal vein circulation but a drop in hepatic artery blood flow. In an effort to evaluate whether these different responses were related to intrinsic differences in GIP effects , we isolated canine hepatic artery (HAEC) and portal ...
The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.

Distinct Effects of Glucose
Oral glucose load elicits larger insulin secretion and less increase in blood glucose levels than intravenous administration of the equivalent amount of glucose (1, 2). This phenomenon is mostly due to incretins, gut-derived factors including glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) (3, 4).
The incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) play central roles in metabolic and cardiovascular regulation. GLP-1 receptor agonists (GLP-1RAs) are established therapies for type 2 diabetes mellitus (T2DM) and obesity because of their insulinotropic effects , weight reduction, and proven cardiovascular benefit in trial level. In ...

Overview of Differential Effects Of Glucose Dependent Insulinotropic
Glucose-dependent insulinotropic polypeptide (GIP) was the first incretin identified and plays an essential role in the maintenance of glucose tolerance in healthy humans. Until recently GIP had not been developed as a therapeutic and thus has been ...
Glucose-dependent insulinotropic polypeptide (GIP) was the first incretin identified and plays an essential role in the maintenance of glucose toleran…

Key Details About Differential Effects Of Glucose Dependent Insulinotropic
Under normal conditions, glucose-dependent insulinotropic polypeptide (GIP) plays a major role in nutrient deposition and storage, and is overexpressed in obese individuals, which may exacerbate insulin resistance manifested by many patients with type 2 diabetes mellitus.








The incretin axis is an essential component of postprandial insulin secretion and glucose homeostasis. There are two incretin hormones, glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which exert multiple actions throughout the body. A key cellular target for the incretins are pancreatic β-cells, where they potentiate nutrient-stimulated insulin ...